Search results
Male Birth Control Gel Is Proving Safe and Effective in Early Clinical Trials
Teen Vogue via Yahoo News· 2 days agoWhile this study shows initial results that are promising, the study will continue to test the...
CG Oncology reports promising bladder cancer trial results By Investing.com
Investing.com· 1 day agoCG Oncology, Inc. (NASDAQ: CGON), a biopharmaceutical company engaged in the development of oncology...
Brookline Capital starts SAB Biotherapeutics stock with $8 PT, buy rating By Investing.com
Investing.com· 8 hours agoThe firm is optimistic about the company's developmental therapy SAB-142, which is aimed at...
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
Valley City Times Record· 6 days agoThe company will showcase the latest clinical trial findings for IMC001 in a poster presentation and...
...Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of...
KOIN News 6 Portland· 5 days agoKeymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a...
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 1 day agoThe docs for Eli Lilly’s donanemab advisory committee meeting are in: the FDA has raised concerns...
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC...
Forrest City Times-Herald· 6 days agoThe preliminary result of the trial was accepted as a late-breaking abstract and selected for oral presentation at the clinical science symposium of lung ...
FDA approves Geron’s RYTELO for MDS associated anaemia
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe FDA's decision is grounded in the positive results from the IMerge Phase III clinical trial....
Newswise Expert | Debora Bruno, Case Western Reserve University
Newswise· 19 hours agoDr. Bruno is a medical oncologist and clinical researcher with a focus on lung cancer and other thoracic malignancies such as thymomas/thymic carcinomas as well as mesothelioma ...
Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
Salon.com· 2 hours agoBack in 2016, Rosalind Watts volunteered to work on one of Imperial College London’s early trials...